NewEdge Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.1K | Buy |
|
|||||
|
2025
Q1 | $65.9K | Sell |
|
|||||
|
2024
Q4 | $96.7K | Sell |
|
|||||
|
2024
Q3 | $127K | Sell |
|
|||||
|
2024
Q2 | $478K | Sell |
|
|||||
|
2024
Q1 | $905K | Buy |
|
|||||
|
2023
Q4 | $553K | Buy |
|
|||||
|
2023
Q3 | $403K | Buy |
|
|||||
|
2023
Q2 | $389K | Buy |
|
|||||
|
2023
Q1 | $355K | Buy |
|
|||||
|
2022
Q4 | $263K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $1.78M | Buy |
|
|||||
|
2021
Q2 | $1.3M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.18K | Buy |
|